170 related articles for article (PubMed ID: 27108412)
1. MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis.
Bonella F; Long X; Ohshimo S; Horimasu Y; Griese M; Guzman J; Kohno N; Costabel U
Orphanet J Rare Dis; 2016 Apr; 11():48. PubMed ID: 27108412
[TBL] [Abstract][Full Text] [Related]
2. Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis.
Bonella F; Ohshimo S; Miaotian C; Griese M; Guzman J; Costabel U
Orphanet J Rare Dis; 2013 Apr; 8():53. PubMed ID: 23557396
[TBL] [Abstract][Full Text] [Related]
3. Serum KL-6 in pulmonary alveolar proteinosis: China compared historically with Germany and Japan.
Guo WL; Zhou ZQ; Chen L; Su ZQ; Zhong CH; Chen Y; Li SY
J Thorac Dis; 2017 Feb; 9(2):287-295. PubMed ID: 28275476
[TBL] [Abstract][Full Text] [Related]
4. MUC1 in lung adenocarcinoma: cross-sectional genetic and serological study.
Horimasu Y; Ishikawa N; Tanaka S; Hirano C; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N; Kohno N
BMC Cancer; 2017 Apr; 17(1):263. PubMed ID: 28403862
[TBL] [Abstract][Full Text] [Related]
5. Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome.
Remuzgo-Martínez S; Atienza-Mateo B; Ocejo-Vinyals JG; Genre F; Pulito-Cueto V; Mora-Cuesta VM; Iturbe-Fernández D; Lera-Gómez L; Pérez-Fernández R; Prieto-Peña D; Irure J; Romero-Bueno F; Sanchez-Pernaute O; Alonso-Moralejo R; Nuño L; Bonilla G; Vicente-Rabaneda EF; Grafia I; Prieto-González S; Narvaez J; Trallero-Araguas E; Selva-O'Callaghan A; ; ; Gualillo O; Cavagna L; Cifrián JM; Renzoni EA; Castañeda S; López-Mejías R; González-Gay MA
Sci Rep; 2021 Nov; 11(1):22574. PubMed ID: 34799647
[TBL] [Abstract][Full Text] [Related]
6. Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levels.
Horimasu Y; Hattori N; Ishikawa N; Kawase S; Tanaka S; Yoshioka K; Yokoyama A; Kohno N; Bonella F; Guzman J; Ohshimo S; Costabel U
Respir Med; 2012 Dec; 106(12):1756-64. PubMed ID: 22995277
[TBL] [Abstract][Full Text] [Related]
7. [The clinical significance of the levels of serum KL-6 mucin and interleukin-13 in pulmonary alveolar proteinosis].
Zhou J; Xiao Y; Ding J; Zhou K; Zhou Z; Cai H
Zhonghua Jie He He Hu Xi Za Zhi; 2015 Feb; 38(2):110-4. PubMed ID: 25908420
[TBL] [Abstract][Full Text] [Related]
8. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis.
Takahashi T; Munakata M; Suzuki I; Kawakami Y
Am J Respir Crit Care Med; 1998 Oct; 158(4):1294-8. PubMed ID: 9769294
[TBL] [Abstract][Full Text] [Related]
9. Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosis.
Bonella F; Long X; He X; Ohshimo S; Griese M; Guzman J; Costabel U
Respirology; 2017 Oct; 22(7):1371-1378. PubMed ID: 28569052
[TBL] [Abstract][Full Text] [Related]
10. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases.
Ishikawa N; Hattori N; Yokoyama A; Kohno N
Respir Investig; 2012 Mar; 50(1):3-13. PubMed ID: 22554854
[TBL] [Abstract][Full Text] [Related]
11. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis.
Lin FC; Chen YC; Chang SC
Mayo Clin Proc; 2008 Dec; 83(12):1344-9. PubMed ID: 19046553
[TBL] [Abstract][Full Text] [Related]
12. Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis.
Shigemura M; Nasuhara Y; Konno S; Shimizu C; Matsuno K; Yamguchi E; Nishimura M
J Transl Med; 2012 Jul; 10():111. PubMed ID: 22650152
[TBL] [Abstract][Full Text] [Related]
13. Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression.
Stock CJW; Hoyles RK; Daccord C; Kokosi M; Visca D; De Lauretis A; Alfieri V; Kouranos V; Margaritopoulos G; George PM; Molyneaux PL; Chua F; Maher TM; Abraham DJ; Ong V; Donovan J; Sestini P; Denton CP; Wells AU; Renzoni EA
Respirology; 2021 May; 26(5):461-468. PubMed ID: 33336433
[TBL] [Abstract][Full Text] [Related]
14. Common Genetic Variants of PSCA, MUC1 and PLCE1 Genes are not Associated with Colorectal Cancer.
Kupcinskas J; Gyvyte U; Bruzaite I; Leja M; Kupcinskaite-Noreikiene R; Pauzas H; Tamelis A; Jonaitis L; Skieceviciene J; Kiudelis G
Asian Pac J Cancer Prev; 2015; 16(14):6027-32. PubMed ID: 26320491
[TBL] [Abstract][Full Text] [Related]
15. Serum KL-6 levels predict clinical outcomes and are associated with
Azekawa S; Chubachi S; Asakura T; Namkoong H; Sato Y; Edahiro R; Lee H; Tanaka H; Otake S; Nakagawara K; Fukushima T; Watase M; Sakurai K; Kusumoto T; Masaki K; Kamata H; Ishii M; Hasegawa N; Okada Y; Koike R; Kitagawa Y; Kimura A; Imoto S; Miyano S; Ogawa S; Kanai T; Fukunaga K;
BMJ Open Respir Res; 2023 May; 10(1):. PubMed ID: 37230764
[TBL] [Abstract][Full Text] [Related]
16. MUC1 and estrogen receptor alpha gene polymorphisms in dry eye patients.
Imbert Y; Foulks GN; Brennan MD; Jumblatt MM; John G; Shah HA; Newton C; Pouranfar F; Young WW
Exp Eye Res; 2009 Mar; 88(3):334-8. PubMed ID: 18619437
[TBL] [Abstract][Full Text] [Related]
17. Changes in pulmonary tissue structure and KL-6/MUC1 expression in a newborn rat model of hyperoxia-induced bronchopulmonary dysplasia.
Zhu Y; Fu J; You K; Jin L; Wang M; Lu D; Xue X
Exp Lung Res; 2013 Dec; 39(10):417-26. PubMed ID: 24298937
[TBL] [Abstract][Full Text] [Related]
18. KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndrome.
Kida Y; Ohshimo S; Ota K; Tamura T; Otani T; Une K; Sadamori T; Iwasaki Y; Bonella F; Hattori N; Hirohashi N; Guzman J; Costabel U; Kohno N; Tanigawa K
Orphanet J Rare Dis; 2012 Dec; 7():99. PubMed ID: 23244165
[TBL] [Abstract][Full Text] [Related]
19. The effect of MUC1 rs4072037 functional polymorphism on cancer susceptibility: evidence from published studies.
Duan F; Song C; Dai L; Cui S; Zhang X; Zhao X
PLoS One; 2014; 9(4):e95651. PubMed ID: 24755768
[TBL] [Abstract][Full Text] [Related]
20. Plasma Mucin-1 (CA15-3) Levels in Autosomal Dominant Tubulointerstitial Kidney Disease due to MUC1 Mutations.
Vylet'al P; Kidd K; Ainsworth HC; Springer D; Vrbacká A; Přistoupilová A; Hughey RP; Alper SL; Lennon N; Harrison S; Harden M; Robins V; Taylor A; Martin L; Howard K; Bitar I; Langefeld CD; Barešová V; Hartmannová H; Hodaňová K; Zima T; Živná M; Kmoch S; Bleyer AJ
Am J Nephrol; 2021; 52(5):378-387. PubMed ID: 34098564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
